Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Clelia Di Salvo"'
Autor:
Elena Lucarini, Laura Benvenuti, Clelia Di Salvo, Vanessa D’Antongiovanni, Carolina Pellegrini, Giulia Valdiserra, Clara Ciampi, Luca Antonioli, Christian Lambiase, Lorenzo Cancelli, Antonio Grosso, Lorenzo Di Cesare Mannelli, Massimo Bellini, Carla Ghelardini, Matteo Fornai
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
IntroductionVisceral pain represents the most common digestive issue, frequently resulting from long-term inflammation, such as inflammatory bowel diseases. The lack of effective drugs prompted search of new therapeutic approaches. In this regard, ga
Externí odkaz:
https://doaj.org/article/bf1182f9464e427895e057bd023e195d
Autor:
Laura Benvenuti, Clelia Di Salvo, Gabriele Bellini, Luisa Seguella, Francesco Rettura, Giuseppe Esposito, Luca Antonioli, Roberto Ceravolo, Nunzia Bernardini, Carolina Pellegrini, Matteo Fornai
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Parkinson’s disease (PD) is a common and slow-progressing neurodegenerative disorder characterized by motor and non-motor symptoms, including gastrointestinal (GI) dysfunctions. Over the last years, the microbiota-gut-brain (MGB) axis is emerging a
Externí odkaz:
https://doaj.org/article/30f70e78f2724b21a92f14486f03cf72
Autor:
Adelaide Panattoni, Marco Calvigioni, Laura Benvenuti, Vanessa D’Antongiovanni, Carolina Pellegrini, Clelia Di Salvo, Diletta Mazzantini, Francesco Celandroni, Matteo Fornai, Luca Antonioli, Emilia Ghelardi
Publikováno v:
Frontiers in Microbiology, Vol 13 (2022)
Microorganisms with probiotic properties are eliciting an increasing interest as coadjuvants in the prevention and treatment of obesity through modulation of the gut microbiota. In this study, a probiotic formulation based on Enterococcus faecium SF6
Externí odkaz:
https://doaj.org/article/1f4f42cf811c4bc48312538af953c684
Autor:
Vanessa D’Antongiovanni, Matteo Fornai, Laura Benvenuti, Clelia Di Salvo, Carolina Pellegrini, Federica Cappelli, Stefano Masi, Luca Antonioli
Publikováno v:
Metabolites, Vol 13, Iss 3, p 410 (2023)
Intestinal epithelial barrier (IEB) impairment and enteric inflammation are involved in the onset of obesity and gut-related dysmotility. Dietary supplementation with natural plant extracts represents a useful strategy for the management of body weig
Externí odkaz:
https://doaj.org/article/ce77130df4ab480d8120fd7e889eb46b
Autor:
Vanessa D’Antongiovanni, Carolina Pellegrini, Luca Antonioli, Laura Benvenuti, Clelia Di Salvo, Lorenzo Flori, Rebecca Piccarducci, Simona Daniele, Alma Martelli, Vincenzo Calderone, Claudia Martini, Matteo Fornai
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Palmitoylethanolamide (PEA), an endogenous lipid mediator, is emerging as a promising pharmacological agent in multiple neurodegenerative disorders for its anti-inflammatory and neuroprotective properties. However, its effects on enteric inflammation
Externí odkaz:
https://doaj.org/article/ed043e7773534734a848874c29ef353a
Autor:
Laura Benvenuti, Vanessa D'Antongiovanni, Carolina Pellegrini, Matteo Fornai, Nunzia Bernardini, Chiara Ippolito, Cristina Segnani, Clelia Di Salvo, Rocchina Colucci, Alma Martelli, Lorenzo Flori, Vincenzo Calderone, Gianfranca Carta, Emilia Ghelardi, Marco Calvigioni, Adelaide Panattoni, Raffaella Coppolecchia, Achille Arini, Luca Antonioli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9ad64f990d4e8deff916a7b99dfc1ce
https://hdl.handle.net/11577/3479837
https://hdl.handle.net/11577/3479837
Autor:
Adelaide, Panattoni, Marco, Calvigioni, Laura, Benvenuti, Vanessa, D'Antongiovanni, Carolina, Pellegrini, Clelia, Di Salvo, Diletta, Mazzantini, Francesco, Celandroni, Matteo, Fornai, Luca, Antonioli, Emilia, Ghelardi
Publikováno v:
Frontiers in microbiology. 13
Microorganisms with probiotic properties are eliciting an increasing interest as coadjuvants in the prevention and treatment of obesity through modulation of the gut microbiota. In this study, a probiotic formulation based on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1aa60ddfe2c93a01e9cd1724f07263f8
https://pubmed.ncbi.nlm.nih.gov/36590404
https://pubmed.ncbi.nlm.nih.gov/36590404
Autor:
Carolina, Pellegrini, Colucci, ROCCHINA LUCIA, Laura, Benvenuti, Vanessa, D'Antongiovanni, Clelia Di Salvo, Simone, Gastaldi, Federica, Blua, Elisabetta, Marini, Barbara, Rolando, Lorettalazzarato, Nunzia, Bernardini, Luca, Antonioli, Massimo, Bertinaria, Matteo, Fornai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3657::edb05b87c19cf784f8f4dac6317b5e91
http://hdl.handle.net/11577/3456808
http://hdl.handle.net/11577/3456808
Autor:
Vanessa D’Antongiovanni, Carolina Pellegrini, Laura Benvenuti, Matteo Fornai, Clelia Di Salvo, Gianfranco Natale, Larisa Ryskalin, Lorenzo Bertani, Elena Lucarini, Lorenzo Di Cesare Mannelli, Carla Ghelardini, Zoltan H. Nemeth, György Haskó, Luca Antonioli
Abstract The pharmacological blockade of P2X4 receptors has shown potential benefits in the management of several immune/inflammatory diseases. However, data regarding the involvement of P2X4 receptors in the pathophysiological mechanisms of action i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e344f5de1fccc647ccf0f67a38143ca1
https://doi.org/10.21203/rs.3.rs-1195241/v1
https://doi.org/10.21203/rs.3.rs-1195241/v1
Autor:
Rocchina Colucci, György Haskó, Corrado Blandizzi, Laura Giusti, Concettina La Motta, Won Keun Oh, Zoltan H. Nemeth, Laura Benvenuti, Lorenzo Zallocco, Giorgia Semeghini, Lorenzo Bertani, Francesco Angelucci, Maurizio Ronci, Luca Antonioli, Carolina Pellegrini, Luca Quattrini, Quy Thi Kim Ha, Vanessa D'Antongiovanni, Clelia Di Salvo, Matteo Fornai, Vito Coviello
Publikováno v:
International Journal of Molecular Sciences
Volume 22
Issue 12
International Journal of Molecular Sciences, Vol 22, Iss 6325, p 6325 (2021)
Volume 22
Issue 12
International Journal of Molecular Sciences, Vol 22, Iss 6325, p 6325 (2021)
Acadesine (ACA), a pharmacological activator of AMP-activated protein kinase (AMPK), showed a promising beneficial effect in a mouse model of colitis, indicating this drug as an alternative tool to manage IBDs. However, ACA displays some pharmacodyna
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c80ce2cf81f6226a65b9cba310f1bff
http://europepmc.org/articles/PMC8231528
http://europepmc.org/articles/PMC8231528